Publications
- Ocrelizumab in the treatment of multiple sclerosis - view of a neurologist and immunologist2018 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Ocrelizumab2018 | First Faculty of Medicine
- Treatment intramuscular interferon beta-1a2013 | First Faculty of Medicine
- Natalizumab in the treatment of multiple sclerosis2011 | First Faculty of Medicine
- Treatment of relapsing-remitting multiple sclerosis2008 | First Faculty of Medicine
- Contemporary treatment of relapsing-remitting multiple sclerosis and future perspectives2008 | First Faculty of Medicine
- Interferon beta and the state of the art in treatment of relapsing-remitting multiple sclerosis +12007 | First Faculty of Medicine
- Interferon beta and the state of the art in treatment of relapsing-remitting multiple sclerosis2007 | Publication without faculty affiliation
- The correlation between ApoEgenotype and clinical and MRI parametrs in relapsing-remitting multiple sclerosis clinical and MRIdata from 2-years double blind, randomised, placebo controled studyPublication without faculty affiliation
- Phase IIb trial of MBP encoding DNA plasmid (BHT-3009) for the treatment of relapsing-remitting multiple sclerosisPublication without faculty affiliation
Loading network view...